Inhibition of plasminogen activator inhibitor-1 activity results in promotion of endogenous thrombolysis and inhibition of thrombus extension in models of experimental thrombosis.
Author(s) -
Marcel Levi,
Bart J. Biemond,
Anton Jan van Zonneveld,
J W ten Cate,
Hans Pannekoek
Publication year - 1992
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/01.cir.85.1.305
Subject(s) - thrombolysis , thrombus , medicine , in vivo , plasminogen activator , platelet , fibrinolysis , pharmacology , plasminogen activator inhibitor 1 , monoclonal antibody , thrombosis , tissue plasminogen activator , antibody , immunology , biology , myocardial infarction , microbiology and biotechnology
We investigated the effect of inhibition of plasminogen activator inhibitor-1 (PAI-1) activity by a murine monoclonal anti-human PAI-1 antibody (MAI-12) on in vitro thrombolysis and on in vivo thrombolysis and thrombus extension in an experimental animal model for thrombosis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom